Express Pharma March 2023
India's Foremost Pharma & Biotech Magazine ~ Women's Health: On a Cusp of a Revolution?
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Alembic Pharma gets USFDA nod for Docetaxel Injection USP
Docetaxcel Injections are indicated for breast cancer, non-small cell lung cancer, castration-resistant prostate cancer, gastric…
Enzene Biosciences begins commercial supply of its biosimilar of Adalimumab
This is the company’s fourth biosimilar launch in recent times
AstraZeneca gets regulatory nod for its molecule Selumetinib in India
AstraZeneca completed the acquisition of Alexion in the year 2021 and is now expanding its portfolio globally to bring innovative…
Sanofi receives SEC recommendation to bring new therapies of Pompe, ASMD to India
The company hopes to launch these therapies in India by end of 2023 or beginning of next year, subject to completion of all…
Biliary tract cancer drug Durvalumab approval key opportunity for AstraZeneca in India: GlobalData
Imfinzi is the only immunotherapy-based combination treatment option in India that offers significantly improved survival rates in…
Venus Remedies gets Saudi GMP approval for production facilities in Baddi
Venus Remedies has received three additional facility approvals and successfully renewed four existing facility approvals from…
Dr Reddy’s to acquire Mayne Pharma’s US generic prescription product portfolio
Dr Reddy's Laboratories has entered into a definitive agreement to acquire the US generic prescription product portfolio of…
Novel pipeline therapies to drive diabetic neuropathic pain market across 7MM to $3 bn in 2031:…
The growth will be driven by the potential introduction of four promising late-stage pipeline products and an increase in the…
Aster launches 250th pharmacy in India
Aster has added its 250th location in 23 months. Now operating in Karnataka, Kerala, Telangana and Andhra Pradesh, Aster Pharmacy…